Equity Capital Markets, Financing

Enfusion

10/21
|
$366.6 Million
Piper Sandler served as co-manager for enfusion on its initial public offering
Sub-Type
IPO
Sector
Financial Services



Sub-Sector
FinTech

Related Transactions

All Transactions
$103.2 Million
Merchants Bancorp
Merchants Bancorp
Passive Bookrunner
$184.7 Million
Skyward Specialty Insurance
Skyward Specialty Insurance
Passive Bookrunner
$100.0 Million
Context Therapeutics LLC
Context Therapeutics LLC
Sole Placement Agent
$201.2 Million
Nurix Inc.
Nurix Inc.
Active Bookrunner
$150.0 Million
Blue Ridge Bankshares
Blue Ridge Bankshares, Inc.
PIPE
Sole Placement Agent
$200.0 Million
Praxis Precision Medicines
Praxis Precision Medicines, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$100.0 Million
Boundless Bio, Inc.
Boundless Bio, Inc.
Initial Public Offering
Active Bookrunner
$30.5 Million
Eagle Point Income Company Inc.
Eagle Point Income Company, Inc.
Series C Term Preferred
Active Bookrunner
$75.0 Million
Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$600.0 Million
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$50.0 Million
Unicycive
Unicycive Therapeutics
PIPE
Joint Placement Agent
$40.0 Million
Skye Bioscience
Skye Bioscience
PIPE
Sole Placement Agent
$100.0 Million
Ventyx Biosciences
Ventyx Biosciences
PIPE
Joint Placement Agent
$30.0 Million
milestone
Milestone Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$1.1 Billion
Applovin
Applovin
Confidentially Marketed Follow-On Offering
Passive Bookrunner
$201.5 Million
New Amsterdam Pharma N.V.
New Amsterdam Pharma N.V.
Confidentially Marketed Follow-On Offering
Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.